Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

MABPHARM-B

0.485
0.000
Volume:- -
Turnover:- -
Market Cap:2.00B
PE:-14.28
High:0.485
Open:0.485
Low:0.485
Close:0.485
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
MABPHARM-B
Exchange:
SEHK
Establishment Date:
2018
Employees:
315
Office Location:
Block G79,Lujia Road East,Koutai Road West,China Medical City,Taizhou,Zhejiang Province,China
Website:
http://www.mabpharm.cn
Zip Code:
225300
Phone:
86 52 3806 60808
Fax:
86 52 3821 08855
Introduction:
Mabpharm Ltd is China-based company mainly engaged in the research, development and production of monoclonal antibody drugs for cancers and autoimmune diseases. The Company's main products include omalizumab (CMAB007), cetuximab (CMAB009) and infliximab (CMAB008). The Company mainly conducts its businesses in China market.

Directors

Name
Position
Jiao Shu Ge
Chairman of the Board,Director,Audit Committee Member
WANG Hao
Executive Director,Member of the Remuneration and Assessment Committee
LI Yun Feng
Executive Director
TAO Jing
Executive Director,Member of the Nomination Committee
HOU Sheng
Executive Director
QIAN Wei Zhu
Executive Director
GUO Liang Zhong
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
ZHANG Yan Yun
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
LIANG Hao Ming
Independent Director,Audit Committee Chairman
TAO Qian
Independent Director
CEN Jia Lin
Director

Shareholders

Name
Position
WANG Hao
CEO,Other Senior Executives
TAO Jing
Vice General Manager
LI Yun Feng
Vice General Manager,Corporate Secretary
QIAN Wei Zhu
Vice General Manager
HOU Sheng
Vice General Manager
CENG Hao Xian
Corporate Secretary